Pfizer raised its forecast for annual sales of its COVID vaccine to $34 billion on demand for Omicron-targeted boosters, helping allay some investor worries over growth for the vaccinations.

#pfizer #covid #coronavirus #health #omicron #booster #News #Reuters #newsfeed

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en